KRG inhibits mitochondrial fission by enhancing DRP-1 (ser637) phosphorylation, thereby reducing cell proliferation and promoting apoptosis, effectively alleviating BPH symptoms. The gene discussed is DNM1L; the disease is benign prostatic hyperplasia.